Landos Biopharma Inc (LABP)

Landos Biopharma Inc Azioni (LABP) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	174.28% 0.491	-0.661	0.517	0.445	-
Operating Expenses	27.14% 6.61	5.199	4.439	6.479	6.513
Benefits Costs and Expenses	27.14% 6.61	5.199	4.439	6.479	-
Costs And Expenses	27.14% 6.61	5.199	4.439	6.479	-
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	27.14% -6.61	-5.199	-4.439	-6.479	-6.513
Net Interest Income/Expense	174.28% 0.491	-0.661	0.517	0.445	-
Interest Income/Expense After Provision For Losses	174.28% 0.491	-0.661	0.517	0.445	-
Income/Loss From Continuing Operations Before Tax	4.42% -6.119	-5.86	-3.922	-6.034	-5.232
Income/Loss From Continuing Operations After Tax	4.42% -6.119	-5.86	-3.922	-6.034	-5.232
Net Income/Loss	4.42% -6.119	-5.86	-3.922	-6.034	-5.232
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	100.37% -0.023	6.2076	6.2077	64.84	-
Diluted Average Shares	100.37% -0.023	6.2076	6.2077	64.84	-
Basic Earnings Per Share	5.32% -0.99	-0.94	-0.63	-0.09	-0.13
Diluted Earnings Per Share	5.32% -0.99	-0.94	-0.63	-0.09	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-